FDA Approved: PROCHLORPERAZINE MALEATE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved a supplemental application for Prochlorperazine Maleate from Chartwell RX, LLC, indicating an approved change under an existing ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nausea
• Postoperative Nausea and Vomiting
• Vertigo
• Vomiting

Drugs mentioned

• PROCHLORPERAZINE MALEATE (prochlorperazine maleate)

Snippet

SUPPL AP for PROCHLORPERAZINE MALEATE (PROCHLORPERAZINE MALEATE)